KRAVICZ MARCELO HENRIQUE
Pubblicazioni
Persico, A., Molteni, L., Mantecca, P., Kravicz, M., Bragato, C. (2025). Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-00258-1]. Dettaglio
Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio
Kravicz, M., Taiarol, L., Viegas, J., Sierri, G., Mauri, M., Koch, M., et al. (2024). Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 101(Part A November 2024) [10.1016/j.jddst.2024.106238]. Dettaglio
Pagnacco, C., Kravicz, M., Sica, F., Fontanini, V., González de San Román, E., Lund, R., et al. (2024). In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions. BIOMACROMOLECULES, 25(6), 3583-3595 [10.1021/acs.biomac.4c00210]. Dettaglio
Sierri, G., Patrucco, M., Ferrario, D., Renda, A., Comi, S., Ciprandi, M., et al. (2024). Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY, 16(5 (September/October 2024)) [10.1002/wnan.1991]. Dettaglio